Ben-Ezra J, Stastny J F, Harris A C, Bork L, Frable W J
Department of Pathology, Medical College of Virginia, Richmond 23298.
Am J Clin Pathol. 1994 Oct;102(4):439-42. doi: 10.1093/ajcp/102.4.439.
The clinical microscopy (fluids) laboratory evaluates almost every body fluid that is obtained in the hospital. Because the fluids laboratory functions at all hours, it is often the first laboratory to receive a body fluid. In addition to its primary purpose of quantitating categories of cells, the medical technologist in this laboratory has an opportunity to identify malignant cells. To our knowledge, no formal study has ever been undertaken to evaluate the performance of the fluids laboratory in detecting malignancy. The authors therefore retrospectively identified 928 body fluids (pleural, peritoneal, cerebrospinal, and miscellaneous) over a 2-year period that had undergone simultaneous cytologic examination in our cytopathology laboratory and body fluid analysis in our fluids laboratory. Of these, a cytologic diagnosis of malignancy was made by the cytopathology laboratory in 107 cases; 821 were considered to be benign. No false-positive results were rendered by the fluids laboratory (100% specificity), but only 26 of the 107 malignant cases were identified (24% sensitivity); the overall accuracy was 93%. Factors contributing to the inability of the fluids laboratory to identify malignant cells included (1) too few cells to warrant a cytocentrifuge preparation, especially in cerebrospinal fluid specimens; (2) differences in the processing of specimens; (3) differences in staining procedures; and (4) differences in the training of personnel. The authors conclude that although the fluids laboratory correctly identifies neoplastic cells in approximately one fourth of the cases in which they are present, it should not be expected to detect malignant cells in every cytologically malignant case.(ABSTRACT TRUNCATED AT 250 WORDS)
临床显微镜检查(体液)实验室几乎对医院获取的每一种体液进行评估。由于体液实验室随时都在运作,它往往是第一个接收体液的实验室。除了对细胞类别进行定量的主要目的外,该实验室的医学技术人员还有机会识别恶性细胞。据我们所知,尚未进行过正式研究来评估体液实验室在检测恶性肿瘤方面的表现。因此,作者回顾性地确定了在两年时间内的928份体液(胸腔、腹腔、脑脊液和其他),这些体液在我们的细胞病理学实验室同时进行了细胞学检查,并在我们的体液实验室进行了体液分析。其中,细胞病理学实验室对107例做出了恶性细胞学诊断;821例被认为是良性的。体液实验室没有给出假阳性结果(特异性为100%),但在107例恶性病例中仅识别出26例(敏感性为24%);总体准确率为93%。导致体液实验室无法识别恶性细胞的因素包括:(1)细胞数量过少,不足以进行细胞离心涂片制备,尤其是在脑脊液标本中;(2)标本处理方式的差异;(3)染色程序的差异;(4)人员培训的差异。作者得出结论,尽管体液实验室在大约四分之一存在肿瘤细胞的病例中能够正确识别肿瘤细胞,但不应期望它在每一例细胞学诊断为恶性的病例中都能检测到恶性细胞。(摘要截短为250字)